Chinese researchers have developed an innovative intratumoral vaccine molecule that prevents cancer cells from suppressing immune function while redirecting the body’s pre-existing immune memory to attack tumours, offering a novel approach to cancer treatment.
Scientists from Shenzhen Bay Laboratory and Peking University reported the findings in a study published online in the journal
